MXPA03007142A - Derivados de carbolina. - Google Patents
Derivados de carbolina.Info
- Publication number
- MXPA03007142A MXPA03007142A MXPA03007142A MXPA03007142A MXPA03007142A MX PA03007142 A MXPA03007142 A MX PA03007142A MX PA03007142 A MXPA03007142 A MX PA03007142A MX PA03007142 A MXPA03007142 A MX PA03007142A MX PA03007142 A MXPA03007142 A MX PA03007142A
- Authority
- MX
- Mexico
- Prior art keywords
- chemical compounds
- compounds
- solvates
- salts
- structural formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se describen compuestos de la formula estructural general (I) y el uso de los compuestos y salas y solvatos de los mismos, como agentes terapeuticos. En particular, la invencion se refiere a compuestos que son inhibidores potentes y selectivos de la fosfodiesterasa especifica de 3',5'-monofosfato da guanosina ciclico (PDE especifico de GMPc), en particular PDES, y tienen utilidad en una variedad de areas terapeuticas en las cuales dicha inhibicion se considera benefica.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26815401P | 2001-02-12 | 2001-02-12 | |
PCT/US2002/000017 WO2002064591A2 (en) | 2001-02-12 | 2002-01-03 | Carboline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03007142A true MXPA03007142A (es) | 2004-05-24 |
Family
ID=23021717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03007142A MXPA03007142A (es) | 2001-02-12 | 2002-01-03 | Derivados de carbolina. |
Country Status (10)
Country | Link |
---|---|
US (1) | US7122554B2 (es) |
EP (1) | EP1360186B1 (es) |
JP (1) | JP4223285B2 (es) |
AT (1) | ATE346067T1 (es) |
AU (1) | AU2002249890A1 (es) |
CA (1) | CA2437718C (es) |
DE (1) | DE60216233T2 (es) |
ES (1) | ES2272695T3 (es) |
MX (1) | MXPA03007142A (es) |
WO (1) | WO2002064591A2 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2524125A1 (en) * | 2003-04-29 | 2004-11-11 | Oscient Pharmaceuticals | Antibiotic tetrahydro-.beta.-carboline derivatives |
US7872133B2 (en) | 2003-06-23 | 2011-01-18 | Ono Pharmaceutical Co., Ltd. | Tricyclic heterocycle compound |
ES2401335T3 (es) | 2004-03-15 | 2013-04-18 | Ptc Therapeutics, Inc. | Derivados de carbolina útiles en la inhibición de la angiogénesis |
US8076353B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Inhibition of VEGF translation |
US8076352B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Administration of carboline derivatives useful in the treatment of cancer and other diseases |
US7767689B2 (en) * | 2004-03-15 | 2010-08-03 | Ptc Therapeutics, Inc. | Carboline derivatives useful in the treatment of cancer |
AR051780A1 (es) * | 2004-11-29 | 2007-02-07 | Japan Tobacco Inc | Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos |
ES2459742T3 (es) * | 2004-12-22 | 2014-05-12 | Ono Pharmaceutical Co., Ltd. | Compuesto tricíclico y uso del mismo |
EP1747779A1 (en) | 2005-07-28 | 2007-01-31 | Laboratorios Del Dr. Esteve, S.A. | Tetrahydro-b-carbolin-sulfonamide derivatives as 5-HT6 ligands |
WO2008127714A1 (en) * | 2007-04-13 | 2008-10-23 | Ptc Therapeutics, Inc. | Administration of carboline derivatives useful in the treatment of cancer and other diseases |
EP2225250A2 (en) | 2007-11-30 | 2010-09-08 | Biota Scientific Management Pty Ltd | Bicyclic ppat inhibitors as antibacterial agents |
AU2009204048B2 (en) | 2008-01-11 | 2013-08-01 | Albany Molecular Research, Inc. | (1-azinone) -substituted pyridoindoles as MCH antagonists |
PT2434891T (pt) | 2009-05-27 | 2020-10-23 | Ptc Therapeutics Inc | Métodos para tratamento de cancro e afeções não neoplásicas |
TW201100419A (en) | 2009-05-27 | 2011-01-01 | Ptc Therapeutics Inc | Processes for the preparation of substituted tetrahydro beta-carbolines |
US8703726B2 (en) | 2009-05-27 | 2014-04-22 | Ptc Therapeutics, Inc. | Methods for treating prostate conditions |
WO2010138652A1 (en) | 2009-05-27 | 2010-12-02 | Ptc Therapeutics, Inc. | Methods for treating kaposi sarcoma |
US9073925B2 (en) | 2009-07-01 | 2015-07-07 | Albany Molecular Research, Inc. | Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof |
US8637501B2 (en) | 2009-07-01 | 2014-01-28 | Albany Molecular Research, Inc. | Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof |
WO2011003007A1 (en) * | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
US8618299B2 (en) * | 2009-07-01 | 2013-12-31 | Albany Molecular Research, Inc. | Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof |
EP2592081B1 (en) * | 2010-07-06 | 2017-03-08 | Ono Pharmaceutical Co., Ltd. | Tetrahydrocarboline derivative |
US8993765B2 (en) | 2010-12-21 | 2015-03-31 | Albany Molecular Research, Inc. | Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof |
WO2012088038A2 (en) | 2010-12-21 | 2012-06-28 | Albany Molecular Research, Inc. | Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof |
ES2587856T3 (es) | 2011-03-18 | 2016-10-27 | Ono Pharmaceutical Co., Ltd. | Derivado de tetrahidrocarbolina |
US11458126B2 (en) | 2017-08-01 | 2022-10-04 | Ptc Therapeutics, Inc. | DHODH inhibitor for use in treating hematologic cancers |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03287586A (ja) * | 1990-04-02 | 1991-12-18 | Taisho Pharmaceut Co Ltd | テトラヒドロ―β―カルボリン誘導体 |
CN1067071C (zh) | 1996-05-10 | 2001-06-13 | 艾科斯有限公司 | 咔啉衍生物 |
UA74826C2 (en) * | 2000-05-17 | 2006-02-15 | Ortho Mcneil Pharm Inc | ?-carboline derivatives as phosphodiesterase inhibitors |
UA72611C2 (uk) * | 2000-05-17 | 2005-03-15 | Орто-Макнейл Фармацевтикал, Інк. | Похідні заміщеного піролопіридинону, корисні як інгібітори фосфодіестерази |
ES2241902T3 (es) | 2000-12-08 | 2005-11-01 | Smithkline Beecham Corporation | Compuestos antibacterianos. |
US7022856B2 (en) | 2001-02-12 | 2006-04-04 | Lilly Icos Llc. | Carboline derivatives |
-
2002
- 2002-01-03 AU AU2002249890A patent/AU2002249890A1/en not_active Abandoned
- 2002-01-03 EP EP02718770A patent/EP1360186B1/en not_active Expired - Lifetime
- 2002-01-03 MX MXPA03007142A patent/MXPA03007142A/es active IP Right Grant
- 2002-01-03 ES ES02718770T patent/ES2272695T3/es not_active Expired - Lifetime
- 2002-01-03 AT AT02718770T patent/ATE346067T1/de not_active IP Right Cessation
- 2002-01-03 WO PCT/US2002/000017 patent/WO2002064591A2/en active IP Right Grant
- 2002-01-03 US US10/470,395 patent/US7122554B2/en not_active Expired - Fee Related
- 2002-01-03 JP JP2002564522A patent/JP4223285B2/ja not_active Expired - Fee Related
- 2002-01-03 DE DE60216233T patent/DE60216233T2/de not_active Expired - Lifetime
- 2002-01-03 CA CA2437718A patent/CA2437718C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2272695T3 (es) | 2007-05-01 |
EP1360186A2 (en) | 2003-11-12 |
WO2002064591A3 (en) | 2002-12-12 |
EP1360186B1 (en) | 2006-11-22 |
CA2437718A1 (en) | 2002-08-22 |
US7122554B2 (en) | 2006-10-17 |
DE60216233D1 (en) | 2007-01-04 |
DE60216233T2 (de) | 2007-09-27 |
ATE346067T1 (de) | 2006-12-15 |
JP4223285B2 (ja) | 2009-02-12 |
US20040116458A1 (en) | 2004-06-17 |
CA2437718C (en) | 2010-03-16 |
WO2002064591A2 (en) | 2002-08-22 |
AU2002249890A1 (en) | 2002-08-28 |
JP2004518730A (ja) | 2004-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60112974D1 (en) | Carbolinderivate | |
MXPA03007142A (es) | Derivados de carbolina. | |
MXPA03002911A (es) | Compuestos quimicos. | |
MXPA02012076A (es) | Compuestos quimicos. | |
MXPA02012659A (es) | Derivados de pirazindiona condensados. | |
GB9514473D0 (en) | Chemical compounds | |
BG108269A (en) | Pyrazolopyrimidines as therapeutic agents | |
BG108268A (en) | Pyrazolopyrimidines as therapeutic agents | |
MXPA03009750A (es) | Compuestos quimicos. | |
GB0124933D0 (en) | Chemical compounds | |
MY135477A (en) | 2-(2,6-dichlorophenyl)-diarylimidazoles | |
MXPA04003886A (es) | Tiofen- y tiazolsulfonamidas como agentes antineoplasticos. | |
WO2002070469A3 (en) | Selective pde3b inhibitors and use of the same in therapy | |
MXPA03002909A (es) | Compuestos quimicos. | |
MXPA02012470A (es) | Inhibidores de fosfodiesterasa especificos para gmp ciclico. | |
GB0018951D0 (en) | Novel compounds | |
MXPA02012472A (es) | Compuestos quimicos. | |
MXPA03003971A (es) | Derivados de indol como inhibidores de pde5. | |
MXPA03004023A (es) | Compuestos quimicos. | |
GB0027705D0 (en) | Novel compounds | |
DE60213798D1 (de) | Carbolinderivate als pdev inhibitoren | |
CA2445620A1 (en) | Tetracyclic compounds as pde5-inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |